{"name":"TiumBio Co., Ltd.","slug":"tiumbio-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"TU2218","genericName":"TU2218","slug":"tu2218","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"TU2218","genericName":"TU2218","slug":"tu2218","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiqgJBVV95cUxPTkRheG11dFNObS1SUFVwcXJXQ1M0QVJpVk1JX2k4VHVKMEJzQTBjQk9GQ0tScWNwUEowXzg0Y3lEQjJKUTlYdjY2Nmd3SUZzVnJSTVk2RmhKSy1oWFk1ZHBIaEQxWU5HRHhFeE15THFwSC1FVmxXZVVuNlZjdWlyMEx6R2dhWXFxalNZRU1fWWNUNENwQmlXanFmcE1yV29lT1EzVmV0ZHFJNzVOQ1ZSaG9lQnVkUEFtS1k4dFQ2bEJoaUwyTUNkWUI2eXFkT1NoMGJLeFhObUlyN04zMUVicTYzSmpYa1FJNC01blBVZGNsTlhMM2lyUzI4SVBjekVwZmNwUWxHUHRVbnB1UnRHdENvS1drSTNkdHpRYkJrSWlPamZmZ2g0d3N3?oc=5","date":"2026-03-12","type":"pipeline","source":"prnewswire.com","summary":"Endometriosis Market Expected to Achieve Significant CAGR During the Forecast Period (2026-2036) Driven by Innovative Treatment Options | DelveInsight - prnewswire.com","headline":"Endometriosis Market Expected to Achieve Significant CAGR During the Forecast Period (2026-2036) Driven by Innovative Tr","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgJBVV95cUxPVzA4RksxZlZJNU9QMVRGYXJRekpLUk5Jb3h6Mzk3UDFPem9zSUtzd2RSQllHbDF3LUdjbEJfYWd3UGV2UmhyT2trQWNfUlR5ZDVLVnlXYXB5czFwVG1mRDEyQWhzNEdac2hCWEk4RDl3aGxSMnpVdTA5U1BrSFBmaGZ1cnZ0MVpNVDktZF9xV0J3ZGRIQk1hbUNKZDJMVlNiUTN5Z0NsWGI5U0ZINnJxNnhWaVpocC1kTHdDWnk1Zl9IemhFQWZsbTZkM0FiaC1YZW1YekxOOHBpRWFWbG55MUQ0bXZCd1p3LS01NDg5cXFoY2Q0M3NrUk9yVjQ2YUlDaUhpeFN2b0loaWhiWW44MmdJTEdNTWtFSFNTemNYTkNEekZkWWc?oc=5","date":"2026-01-22","type":"trial","source":"GlobeNewswire","summary":"Endometriosis Clinical Trial Pipeline Accelerates as 18+ - GlobeNewswire","headline":"Endometriosis Clinical Trial Pipeline Accelerates as 18+","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMijgJBVV95cUxNVzk3RUZNRC1NZWxoNXBfNTNXTzFhdjZ2QU5ORmJFaXowQUtQcDlZeGRxbDB6VDI1T19HZXRzNV9DQlRueE8wNDV1ajhKcUNCUlhhMHYydWZxWjZzQkd4UDZSbVJCWlNTOUdvNjFzVFZwMXRuUzg5RnJCNHN5Qjk5WXNWeE1SWmRybzAyZ3lDbjAtVUVURG54WXllT083VjFGUV81YkxtQjlYMS01a1FKZnpDX3hKVWo5b19NMHl6OWFLbW1seDdaTE51WnJPdzJ1NEhkYmFpTWdyVHRBUmdfc2hETGFEUFFGVlo4MWNyUGUtNHE3ckQzUWM4WldxNUtUYm9ZT0QydjhydTA5Nmc?oc=5","date":"2025-05-07","type":"trial","source":"prnewswire.com","summary":"TiumBio and Daewon Pharmaceutical Successfully Complete Phase 2 Clinical Trial of 'Merigolix (TU2670/DW4902)' for Uterine Fibroids - prnewswire.com","headline":"TiumBio and Daewon Pharmaceutical Successfully Complete Phase 2 Clinical Trial of 'Merigolix (TU2670/DW4902)' for Uterin","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMijgJBVV95cUxQTE0yX3VwZnZudFdTaUxoVjJCaXRJTHVubmJtdzBRSEdYdzZ6Vy1xM1RBQkYzQjJoWmFYVWJVUXFuQ0JtdUtJZVhrTXF3blVMU1MzZUsxSS0zZTdXTDYyR20xTkxIdFhQN0tUbUMtUzZZQVpfYS12TmhWelg0UEo2dGFGdUFkeDl0Z3dRZkw3djQ0dWUxSGtyQWEtNFM4NWtUeUpzcTZ4SFlkOFRTZVFBdTYyWkt0dk1CR1lCaVkzTFhyR3E1Z3FETG9hZC1CLUdNTktfeHFzajd3c0ZkQ1Q5Znp4a1k2YWFkQUdNWi1XZ1hTdzVvempXZTg3TmN2a3ZDWDhuRmN6R2hJX0t1SEE?oc=5","date":"2025-03-21","type":"deal","source":"BioSpace","summary":"TiumBio's Partner Hansoh Pharma Expands Indications for Merigolix (HS-10518) with Initiation of ART (Assisted Reproductive Technology) Development - BioSpace","headline":"TiumBio's Partner Hansoh Pharma Expands Indications for Merigolix (HS-10518) with Initiation of ART (Assisted Reproducti","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8AFBVV95cUxPV1M3NXRQVDYwUnJSS2F0Nlh5LVRJMFlFQjdOMnc3ODczRXVYbmxVRXZCLVFJMDdCRU01ZHZmRkZjcGY1VjlFQWd2WFBuTFNoZ2ZJRTl0Rk9IcTNmUjZyaDE0ZTBHTFJDRFlYYURnT0xRWUlzWUxwX0VoWmZqMThBUVdVS0NnbHAwN2pjRkV2TVJtVS1GWWI4SF9oYnVlUGUya2NjOHpncXBjN0ZpSjV2dk1ST0VYQWhWNTNIdkdLYmU3OEk3UGR3WjNyaFk4aWtfaHF5SUtSZHFJRUdYMW9kMVl5MUVrVU52RVFlRUdQOVE?oc=5","date":"2025-01-29","type":"trial","source":"prnewswire.com","summary":"Endometriosis Clinical Trial Pipeline Gains Momentum as 15+ Key Companies at the Forefront | DelveInsight - prnewswire.com","headline":"Endometriosis Clinical Trial Pipeline Gains Momentum as 15+ Key Companies at the Forefront | DelveInsight","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMibEFVX3lxTFBVcloyUWlTN0pqbXdNTDRpMDljYXUybV82d3c0REMtbjR3WFJNZ2pocUIzZ3FDYmE1WF9RU2ZEaDJhejQ0ZDVjcXZmMEVqNFF3MWdubUpWWWcwcG1OWEFEQ081UFYwRUZEMVl4dA?oc=5","date":"2023-07-05","type":"regulatory","source":"팜뉴스","summary":"TiumBio and Hansoh Pharma Announce Clinical Trial Approval of 'HS-10518/TU2670' from NMPA in China - 팜뉴스","headline":"TiumBio and Hansoh Pharma Announce Clinical Trial Approval of 'HS-10518/TU2670' from NMPA in China - 팜뉴스","sentiment":"positive"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":0,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}